{"DataElement":{"publicId":"7601833","version":"1","preferredName":"Calretinin Protein Expression Immunohistochemistry Status Result","preferredDefinition":"Text term that represents the status of the calretinin protein expression using immunohistochemistry.","longName":"7592038v1.0:6061805v1.0","context":"OCG","contextVersion":"1","DataElementConcept":{"publicId":"7592038","version":"1","preferredName":"Calretinin Protein Expression Immunohistochemistry Staining Method Performed","preferredDefinition":"Calretinin (271 aa, ~32 kDa) is encoded by the human CALB2 gene. This protein is involved in calcium homeostasis._The biosynthesis of new (often sets of distinct, functionally related) protein products, usually involving new mRNA transcripts, typically in response to an activating stimulus._Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen._Executed and carried through to completion.","longName":"7592036v1.0:6072047v1.0","context":"OCG","contextVersion":"1","ObjectClass":{"publicId":"7592036","version":"1","preferredName":"Calretinin","preferredDefinition":"Calretinin (271 aa, ~32 kDa) is encoded by the human CALB2 gene. This protein is involved in calcium homeostasis.","longName":"C123858","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Calretinin","conceptCode":"C123858","definition":"Calretinin (271 aa, ~32 kDa) is encoded by the human CALB2 gene. This protein is involved in calcium homeostasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD3496FC-8C51-0ED7-E053-4EBD850AF5D7","latestVersionIndicator":"Yes","beginDate":"2021-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-10","modifiedBy":"ONEDATA","dateModified":"2021-03-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6072047","version":"1","preferredName":"Protein Expression Immunohistochemistry Staining Method Performed","preferredDefinition":"The biosynthesis of new (often sets of distinct, functionally related) protein products, usually involving new mRNA transcripts, typically in response to an activating stimulus.:Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.:Executed and carried through to completion.","longName":"C18966:C23020:C38000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Protein Expression","conceptCode":"C18966","definition":"The biosynthesis of new (often sets of distinct, functionally related) protein products, usually involving new mRNA transcripts, typically in response to an activating stimulus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Immunohistochemistry Staining Method","conceptCode":"C23020","definition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"653211AF-6AAB-6917-E053-F662850A3254","latestVersionIndicator":"Yes","beginDate":"2018-02-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-14","modifiedBy":"ONEDATA","dateModified":"2018-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD3496FC-8C5F-0ED7-E053-4EBD850AF5D7","latestVersionIndicator":"Yes","beginDate":"2021-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-10","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeDescription":"Created for HCMI: Mesothelioma Curation Request 2.25.2021 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6061805","version":"1","preferredName":"Protein Expression IHC Result","preferredDefinition":"The result of an action.","longName":"6061805v1.0","context":"OCG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Equivocal","valueDescription":"Equivocal","ValueMeaning":{"publicId":"5178198","version":"1","preferredName":"Equivocal","longName":"5178198","preferredDefinition":"Open to question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Equivocal","conceptCode":"C86071","definition":"Open to question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E58EB10-C86C-1000-E050-BB89AD43077B","latestVersionIndicator":"Yes","beginDate":"2016-03-18","endDate":null,"createdBy":"DAVISJ","dateCreated":"2016-03-18","modifiedBy":"COOPERM","dateModified":"2018-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AA7615-33A4-3AB1-E053-F662850A7528","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"Negative","valueDescription":"Negative Finding","ValueMeaning":{"publicId":"2840098","version":"1","preferredName":"Negative Finding","longName":"2840098","preferredDefinition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"635F3981-C786-F359-E040-BB89AD435EC5","latestVersionIndicator":"Yes","beginDate":"2009-02-20","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-20","modifiedBy":"KUMMEROA","dateModified":"2024-02-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AA7615-33AF-3AB1-E053-F662850A7528","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"Positive","valueDescription":"Positive Finding","ValueMeaning":{"publicId":"5042698","version":"1","preferredName":"Positive Finding","longName":"5042698","preferredDefinition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"23BCDB4E-8EE7-8E8D-E050-BB89AD432DF3","latestVersionIndicator":"Yes","beginDate":"2015-11-04","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-11-04","modifiedBy":"KUMMEROA","dateModified":"2024-02-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AA7615-33BA-3AB1-E053-F662850A7528","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"Cannot be determined","valueDescription":"Indeterminate","ValueMeaning":{"publicId":"2558962","version":"1","preferredName":"Indeterminate","longName":"2558962","preferredDefinition":"Cannot distinguish between two or more possible values in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indeterminate","conceptCode":"C48658","definition":"Cannot distinguish between two or more possible values in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B35F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"648DF04E-3926-03A7-E053-F662850AA4EC","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"ONEDATA","dateModified":"2018-02-06","deletedIndicator":"No"},{"value":"Abnormal null expression (complete loss of expression)","valueDescription":"Complete Loss Protein Expression","ValueMeaning":{"publicId":"6689301","version":"1","preferredName":"Complete Loss Protein Expression","longName":"6689301","preferredDefinition":"To possess every necessary or normal part or component or step; having come or been brought to a conclusion.: A gradual decline in amount or activity.: The biosynthesis of new (often sets of distinct, functionally related) protein products, usually involving new mRNA transcripts, typically in response to an activating stimulus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete","conceptCode":"C25250","definition":"To possess every necessary or normal part or component or step; having come or been brought to a conclusion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Loss","conceptCode":"C25559","definition":"A gradual decline in amount or activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Protein Expression","conceptCode":"C18966","definition":"The biosynthesis of new (often sets of distinct, functionally related) protein products, usually involving new mRNA transcripts, typically in response to an activating stimulus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86200CA4-B54B-5487-E053-F662850A8E34","latestVersionIndicator":"Yes","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86200CA4-B564-5487-E053-F662850A8E34","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","deletedIndicator":"No"},{"value":"Abnormal strong diffuse overexpression (>90%)","valueDescription":"Abnormal Strong Diffuse Protein Overexpression","ValueMeaning":{"publicId":"6689302","version":"1","preferredName":"Abnormal Strong Diffuse Protein Overexpression","longName":"6689302","preferredDefinition":"Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.: Having strength, power, or intensity greater than average or expected.: Widely spread; not localized or confined.: In biology, to make too many copies of a protein or other substance. Overexpression of certain proteins or other substances may play a role in cancer development.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Abnormal","conceptCode":"C25401","definition":"Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Strong","conceptCode":"C62223","definition":"Having strength, power, or intensity greater than average or expected.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Diffuse","conceptCode":"C14175","definition":"Widely spread; not localized or confined.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Protein Overexpression","conceptCode":"C18211","definition":"Synthesis of excess polypeptide within the cell. Overexpression is often due to the amplification or deregulation of the gene which encodes the gene product.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86200CA4-B573-5487-E053-F662850A8E34","latestVersionIndicator":"Yes","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86200CA4-B58C-5487-E053-F662850A8E34","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","deletedIndicator":"No"},{"value":"Normal","valueDescription":"Normal Protein Expression","ValueMeaning":{"publicId":"6689303","version":"1","preferredName":"Normal Protein Expression","longName":"6689303","preferredDefinition":"Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.: The biosynthesis of new (often sets of distinct, functionally related) protein products, usually involving new mRNA transcripts, typically in response to an activating stimulus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Normal","conceptCode":"C14165","definition":"Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Protein Expression","conceptCode":"C18966","definition":"The biosynthesis of new (often sets of distinct, functionally related) protein products, usually involving new mRNA transcripts, typically in response to an activating stimulus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86200CA4-B599-5487-E053-F662850A8E34","latestVersionIndicator":"Yes","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86200CA4-B5B2-5487-E053-F662850A8E34","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","deletedIndicator":"No"},{"value":"Not done","valueDescription":"Not Done","ValueMeaning":{"publicId":"4163021","version":"1","preferredName":"Not Done","longName":"4163021","preferredDefinition":"Indicates a task, process or examination that has either not been initiated or not been completed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Done","conceptCode":"C49484","definition":"Indicates a task, process or examination that has either not been initiated or not been completed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F2B5E544-9A39-F7D4-E040-BB89AD4312F7","latestVersionIndicator":"Yes","beginDate":"2014-02-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-02-18","modifiedBy":"KUMMEROA","dateModified":"2023-12-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"98C0E5EC-34C4-7FC4-E053-F662850A326C","beginDate":"2019-12-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-12-02","modifiedBy":"ONEDATA","dateModified":"2019-12-02","deletedIndicator":"No"},{"value":"Present","valueDescription":null,"ValueMeaning":{"publicId":"2562862","version":"1","preferredName":"Present","longName":"2562862","preferredDefinition":"Being or existing in a specified place or at the specified time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C29B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"COOPERM","dateModified":"2018-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E83187EB-E56C-5FAF-E053-731AD00AFB04","beginDate":"2022-09-08","endDate":null,"createdBy":"RAGUNATHANU","dateCreated":"2022-09-08","modifiedBy":"RAGUNATHANU","dateModified":"2022-09-08","deletedIndicator":"No"},{"value":"Absent","valueDescription":null,"ValueMeaning":{"publicId":"2562943","version":"1","preferredName":"Absent","longName":"2562943","preferredDefinition":"Not existing in a specified place at a specified time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Absent","conceptCode":"C48190","definition":"Not existing in a specified place at a specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C2EC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"REEVESD","dateModified":"2014-11-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E83187EB-E56D-5FAF-E053-731AD00AFB04","beginDate":"2022-09-08","endDate":null,"createdBy":"RAGUNATHANU","dateCreated":"2022-09-08","modifiedBy":"RAGUNATHANU","dateModified":"2022-09-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2476191","version":"1","preferredName":"Result","preferredDefinition":"Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"11CE3EF3-93C8-1DC4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-19","modifiedBy":"ONEDATA","dateModified":"2006-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"648DF04E-390E-03A7-E053-F662850AA4EC","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"RAGUNATHANU","dateModified":"2022-09-08","changeDescription":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"7589447","version":"1","longName":"Mesothelioma","context":"OCG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Calretinin expression by IHC","type":"Preferred Question Text","description":"Calretinin expression by IHC","url":null,"context":"OCG"}],"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDAA2D49-89C3-225B-E053-4EBD850A1BED","latestVersionIndicator":"Yes","beginDate":"2021-03-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-16","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeDescription":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}